AP NEWS

Europe Multiple Myeloma Market and Competitive Landscape - 2018 - ResearchAndMarkets.com

November 23, 2018

DUBLIN--(BUSINESS WIRE)--Nov 23, 2018--The “Europe Multiple Myeloma Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

Europe Multiple Myeloma Market and Competitive Landscape - 2018, provides comprehensive insights into Multiple Myeloma pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares.

This study accurately estimates and forecast Multiple Myeloma market size and drug sales. This research also provides insights into Multiple Myeloma epidemiology and late stage pipeline.

The research is classified into following sections - Multiple Myeloma overview with definitions, symptoms, etiology, diagnosis, treatment options; Multiple Myeloma pipeline insights covering late stage clinical trials pipeline; Multiple Myeloma prevalence trends by countries; Multiple Myeloma market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Key Topics Covered

1. Multiple Myeloma: Disease Overview 1.1. Multiple Myeloma Symptoms 1.2. Multiple Myeloma Etiology 1.3. Multiple Myeloma Diagnosis 1.4. Multiple Myeloma Treatment Options

2. Multiple Myeloma Pipeline Insights 2.1. Multiple Myeloma Phase 3 Clinical Trials 2.2. Multiple Myeloma Phase 2 Clinical Trials 2.3. Multiple Myeloma Phase 1 Clinical Trials

3. Multiple Myeloma Epidemiology Analysis

4. Germany Multiple Myeloma Market Insights 4.1. Marketed Products for Multiple Myeloma in Germany 4.2. Germany Multiple Myeloma Market Size & Forecast 4.3. Germany Multiple Myeloma Product Sales Forecast 4.4. Germany Multiple Myeloma Market Share Analysis

5. France Multiple Myeloma Market Insights 5.1. Marketed Products for Multiple Myeloma in France 5.2. France Multiple Myeloma Market Size & Forecast 5.3. France Multiple Myeloma Product Sales Forecast 5.4. France Multiple Myeloma Market Share Analysis

6. Italy Multiple Myeloma Market Insights 6.1. Marketed Products for Multiple Myeloma in Italy 6.2. Italy Multiple Myeloma Market Size & Forecast 6.3. Italy Multiple Myeloma Product Sales Forecast 6.4. Italy Multiple Myeloma Market Share Analysis

7. Spain Multiple Myeloma Market Insights 7.1. Marketed Products for Multiple Myeloma in Spain 7.2. Spain Multiple Myeloma Market Size & Forecast 7.3. Spain Multiple Myeloma Product Sales Forecast 7.4. Spain Multiple Myeloma Market Share Analysis

8. UK Multiple Myeloma Market Insights 8.1. Marketed Products for Multiple Myeloma in UK 8.2. UK Multiple Myeloma Market Size & Forecast 8.3. UK Multiple Myeloma Product Sales Forecast 8.4. UK Multiple Myeloma Market Share Analysis

9. Europe Multiple Myeloma Market Insights 9.1. Europe Multiple Myeloma Market Size & Forecast 9.2. Europe Multiple Myeloma Product Sales Forecast 9.3. Europe Multiple Myeloma Market Share Analysis

10. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/pm4txp/europe_multiple?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181123005163/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Leukemia Drugs

KEYWORD: EUROPE

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/23/2018 09:37 AM/DISC: 11/23/2018 09:36 AM

http://www.businesswire.com/news/home/20181123005163/en

AP RADIO
Update hourly